Molecular Targeting Probes - Radioactive & Nonradioactive -> Dosimetry and Image Analysis 270

270 - Personalized therapy planning for 177Lu-DOTATATE using a kidney-driven dose optimization method (ID 1409)

Session Name
33 - Dosimetry
Speakers
Authors
Presentation Topic
Molecular Targeting Probes - Radioactive & Nonradioactive -> Dosimetry and Image Analysis
Presentation Number
270

Previous Eposter
267 - Clinical utility of a 3D convolutional neural network kidney segmentation method for radionuclide dosimetry (ID 1406)

Next Eposters
292 - Performance of 68Ga-PSMA PET/CT in the guidance of initial prostate cancer biopsy: comparison with two predicting nomograms (ID 630)
295 - Integrin-PET uptake evaluation in patients receiving pulmonary radiotherapy (ID 137)
298 - Fibroblast Activation Protein - specific PET/CT imaging in Idiopathic Pulmonary Fibrosis with Lung Cancer (ID 140)
308 - The Total Perfusion Deficits And Myocardial contractile synchrony disclosed by Gated Myocardial Perfusion Imaging in Differentiated Thyroid Carcinoma Patients with High Risk after TSH Suppression Therapy (ID 1048)
331 - 800CW Dye and 89Zr Dual-labeled Antibody for the PET/NIRF/Cerenkov Multi-modality Imaging of ICAM-1 (CD54) in Pancreatic Cancer (ID 438)
351 - Combination of 177Lu-lilotomab satetraxetan with rituximab synergistically improves in-vivo therapeutic efficacy in a rituximab-resistant non-Hodgkin lymphoma (NHL) model (ID 1000)
355 - Enhancement of astatine (211At) uptake via the sodium iodide symporter by the addition of ascorbic acid in targeted alpha therapy of thyroid cancer (ID 1003)
362 - A Preliminary Investigation with 18F-NaF Dynamic PET/CT Brain Imaging for Primary Intracranial Tumors (ID 598)
363 - Differential diagnosis of radiotherapy injury and recurrent glioma by diffusion kurtosis imaging and 11C-Methionine metabolic imaging with PET/MR (ID 600)
369 - A study on the use of FDG180 via PET-CT for assessing bowel inflammation. (ID 524)